Induction of cyclin-dependent kinase inhibitor, p21WAF1, by treatment with 3,4-dihydro-6-[4-(3,4)-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinoline (vesnarinone) in a human salivary cancer cell line with mutant p53 gene.

Source:http://linkedlifedata.com/resource/pubmed/id/9066726

Cancer Lett. 1997 Jan 30 112 2 181-9

Download in:

View as

General Info

PMID
9066726